98 Chapter 4 SUPPLEMENTARY MATERIAL Antihypertensives Beta-blockers Propranolol, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Carvedilol ACE inhibitors Captopril, Enalapril ARB Losartan, Valsartan, Candesartan, Telmisartan Calcium channel blockers Amlodipine, Nifedipine, Lercanidipine, Verapamil, Diltiazem Diuretics Hydrochlorothiazide, Chlortalidone, Indapamide, Furosemide, Spironolactone, Amiloride Antiplatelets ASA Clopidogrel, Triflusal, Acetylsalicylic acid Lipid-lowering Statins Simvastatin, Rosuvastatin, HMG CoA reductase inhibitors, Lovastatin, Atorvastatin Other lipid-lowering drugs Gemfibrozil, Fenofibrate, Ciprofibrate, Omega-3triglycerides, Ezetimibe Antidiabetics Oral hypoglicemics and insulin Metformin, Glibenclamide, Tolbutamide, Gliclazide, Glimepiride, Sitagliptin, Vildagliptin, Insulin and analogues. Supplementary Table 1. List of medications included in each medication class. Medication Additional coverage Public coverage only Overall p Antiplatelet (any) 28.6 28.1 28.3 0.910 Aspirin 27.6 27.9 27.8 0.948 Antihypertensives (any) 54.4 50.5 51.9 0.424 Beta-blockers 25.3 17.1 20.0 0.021 ACE inhibitors 22.5 31.4 28.2 0.028 ARB 17.6 14.0 15.3 0.297 Calcium channel blockers 9.1 5.7 6.9 0.125 Diuretics 15.6 18.1 17.2 0.469 Lipid-lowering drugs (any) 28.0 22.3 24.4 0.144 Statins 28.0 20.9 23.5 0.068 Oral hypoglicemics (among diabetics) 60.8 52.7 55.9 0.361 Insulin (among diabetics) 3.9 12.3 8.9 0.040 Number of medications (mean (SE)) 1.8 (0.1) 1.8 (0.1) 1.8 (0.1) 0.639 At least one drug 93.1 97.4 95.4 0.077 At least two drugs 61.6 57.8 59.3 0.511 Supplementary Table 2. Percentage of medication use by medication class and insurance status.
RkJQdWJsaXNoZXIy MTk4NDMw